Search

Your search keyword '"Sanz-Pamplona, Rebeca"' showing total 337 results

Search Constraints

Start Over You searched for: Author "Sanz-Pamplona, Rebeca" Remove constraint Author: "Sanz-Pamplona, Rebeca"
337 results on '"Sanz-Pamplona, Rebeca"'

Search Results

3. Germline genetic regulation of the colorectal tumor immune microenvironment

4. Identification of FasL as a crucial host factor driving COVID-19 pathology and lethality

5. MmCMS: mouse models’ consensus molecular subtypes of colorectal cancer

6. CAR Immunotherapy for the treatment of infectious diseases: a systematic review

7. Unraveling the Power of NAP-CNB’s Machine Learning-enhanced Tumor Neoantigen Prediction

8. Author response: Unraveling the Power of NAP-CNB’s Machine Learning-enhanced Tumor Neoantigen Prediction

11. Noninvasive early detection of colorectal cancer by hypermethylation of the LINC00473 promoter in plasma cell-free DNA

12. Author Correction: COLONOMICS - integrative omics data of one hundred paired normal-tumoral samples from colon cancer patients

13. COLONOMICS - integrative omics data of one hundred paired normal-tumoral samples from colon cancer patients

14. Differences in tumor-associated T-cell receptor repertoires between early-onset and average-onset colorectal cancer.

15. dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe

16. Identification of FasL as a crucial host factor driving COVID-19 pathology and lethality

17. Algorithmic Methods to Infer the Evolutionary Trajectories in Cancer Progression

18. Peripheral Blood TCRβ Repertoire, IL15, IL2 and Soluble Ligands for NKG2D Activating Receptor Predict Efficacy of Immune Checkpoint Inhibitors in Lung Cancer.

20. CAR Immunotherapy for the treatment of infectious diseases: a systematic review

21. Role of POLE and POLD1 in familial cancer

24. Unraveling the Power of NAP-CNB's Machine Learning-enhanced Tumor Neoantigen Prediction

25. Heterozygote advantage at HLA class I and II loci and reduced risk of colorectal cancer

26. Driver mutations in GNAQ and GNA11 genes as potential targets for precision immunotherapy in uveal melanoma patients

28. Identification of a Twelve-microRNA Signature with Prognostic Value in Stage II Microsatellite Stable Colon Cancer

30. Supplementary material for Integrated analysis of circulating immune cellular and soluble mediators reveals specific COVID19 signatures at hospital admission with utility for prediction of clinical outcomes [Dataset]

31. Adoptive NK cell transfer as a treatment in colorectal cancer patients: analyses of tumour cell determinants correlating with efficacy in vitro and in vivo

33. Supplementary Figure from A Therapeutically Actionable Protumoral Axis of Cytokines Involving IL-8, TNFα, and IL-1β

34. Abstract 5105: TIMP1 mediates astrocyte-dependent local immunosuppression in brain metastasis

35. Data from A Therapeutically Actionable Protumoral Axis of Cytokines Involving IL-8, TNFα, and IL-1β

36. Supplementary Figure 4 from Noncanonical TGFβ Pathway Relieves the Blockade of IL1β/TGFβ-Mediated Crosstalk between Tumor and Stroma: TGFBR1 and TAK1 Inhibition in Colorectal Cancer

37. Supplementary Table 1 from Exome Sequencing Reveals AMER1 as a Frequently Mutated Gene in Colorectal Cancer

38. supplementary material legends from Exome Sequencing Reveals AMER1 as a Frequently Mutated Gene in Colorectal Cancer

39. Supplementary Table 5 from Exome Sequencing Reveals AMER1 as a Frequently Mutated Gene in Colorectal Cancer

40. Supplementary Table 2 from Exome Sequencing Reveals AMER1 as a Frequently Mutated Gene in Colorectal Cancer

41. Supplementary Table 8 from Exome Sequencing Reveals AMER1 as a Frequently Mutated Gene in Colorectal Cancer

42. Supplementary Table 7 from Exome Sequencing Reveals AMER1 as a Frequently Mutated Gene in Colorectal Cancer

43. Data from Exome Sequencing Reveals AMER1 as a Frequently Mutated Gene in Colorectal Cancer

44. Supplementary Table 3 from Exome Sequencing Reveals AMER1 as a Frequently Mutated Gene in Colorectal Cancer

45. Supplementary Methods, Tables 1-4, Figures 1-7 from Gene Expression Differences between Colon and Rectum Tumors

46. Supplementary Table 4 from Exome Sequencing Reveals AMER1 as a Frequently Mutated Gene in Colorectal Cancer

47. Supplementary Table 6 from Exome Sequencing Reveals AMER1 as a Frequently Mutated Gene in Colorectal Cancer

48. Supplementary Figures from Exome Sequencing Reveals AMER1 as a Frequently Mutated Gene in Colorectal Cancer

49. Extranodal natural killer/T‐cell lymphoma nasal type in a western population: Molecular profiling identifies new therapeutic targets

Catalog

Books, media, physical & digital resources